Determination of Inflammatory and Angiogenic Response of IL-8 and VEGF and the Reduction of this Response by an IL-8-VEGF Bispecific Aptamer Therapeutic
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Drive Therapeutics, LLC
Award Date
Award Amount
250,000
Program Category
Business Financing
Principal Investigator
Douglas Gooding
Fiscal Year
2024
Region
Research Triangle
Project Description:
Drive Therapeutics of Research Triangle Park received $250,000 to develop a novel, long acting, bispecific aptamer therapeutic to mitigate poor patient response to current therapies for retinal diseases including wet age-related macular degeneration (wAMD) and diabetic macular edema (DME).